Last reviewed · How we verify

NCT06758466

Bipolar TURP Versus Bipolar Enucleation for BPH Management

Not yet recruiting NA Last updated 3 January 2025
What this trial tests

NA trial testing Prostate surgery in Benign Prostatic Hyperplasia in 180 participants. Not yet recruiting.

Timeline
15 January 2025
Primary endpoint
15 December 2027
15 March 2028

Quick facts

Lead sponsorKasr El Aini Hospital
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment180
Start date15 January 2025
Primary completion15 December 2027
Estimated completion15 March 2028

Drugs / interventions tested

Conditions studied

Sponsor

Kasr El Aini Hospital

Who can join

Adults 45 to 80, male only, with Benign Prostatic Hyperplasia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To compare the surgical outcomes at 12 months post-surgery between Bipolar TURP and BipoLEP in men with BPH and prostate volumes between 30-80 grams.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Prostate surgery

Trials testing the same drug.

Other recruiting trials for Benign Prostatic Hyperplasia

Currently open trials in the same condition.

Other Kasr El Aini Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06758466.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing